An APP gene test checks younger adults with memory problems for harmful changes in the amyloid precursor protein gene that cause early-onset Alzheimer's disease. Clinical sequencing is highly accurate within the gene regions it analyzes, preparation involves family-history review and counseling plus a blood or cheek-swab sample, and results guide neurology care and family testing.
APP means amyloid-beta precursor protein. The test looks for variants that disrupt how that protein is processed in the brain. It is used alongside clinical evaluation, not as a stand-alone diagnosis of memory loss.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who should consider this test?
- How accurate is APP sequencing?
- How do you prepare for testing?
- What happens after the result?
Who should consider this test?
Adults with memory or thinking problems beginning before age 65 may discuss testing when family history suggests inherited disease. According to the U.S. National Library of Medicine, APP variants cause early-onset Alzheimer's and account for less than 10% of early-onset cases, as described in the MedlinePlus APP gene summary.
Risk rises sharply when a parent, sibling, or child has early-onset disease. According to the U.S. National Library of Medicine, this form is autosomal dominant, so one altered copy is enough and each child of a carrier has a 50% chance of inheriting it, as explained in the MedlinePlus Alzheimer's condition page. A genetics clinician can map who is affected, at what ages, and whether to test an affected relative first.
How accurate is APP sequencing?
Clinical full-gene APP sequencing reports about 99% analytical sensitivity and specificity. According to Indiana University School of Medicine Genetic Testing Laboratories, the test analyzes coding and immediate flanking regions but can miss large deletions or noncoding variants, as stated in the Indiana University APP sequencing test directory. That distinction matters for families. A positive result for a known harmful variant is highly reliable.
A negative result lowers concern for APP but does not rule out Alzheimer's or another genetic cause. APP, PSEN1, and PSEN2 together explain only about 10% to 15% of early-onset familial cases. Many younger adults with memory problems have other causes, including other genes, neurologic conditions, mood disorders, sleep disorders, or medication effects. Test choice should match the clinical and family pattern.
How do you prepare for testing?
Preparation starts with family-history review and pre-test genetic counseling. Counseling guidelines recommend pedigree risk assessment, testing an affected relative first when possible, and discussion of benefits, insurance, employment, and family implications before predictive testing.
According to Evexia Diagnostics, testing typically uses a 4 mL whole-blood sample or cheek swab, analyzes APP with PSEN1 and PSEN2 together, and returns results in about 14 to 28 days, as listed in the Evexia early-onset Alzheimer's test directory. Bring medical records, memory-test results, medication lists, and names, ages, and diagnoses of affected relatives.
- List relatives with dementia, age at onset, and cause if known
- Ask whether an affected parent or sibling can be tested first
- Review privacy, insurance, employment, and family-sharing questions
- Confirm sample type, turnaround time, and how results will be returned
What happens after the result?
A genetics clinician explains whether the result is positive, negative, or uncertain. A positive APP result points to a hereditary cause and prompts neurology follow-up to confirm Alzheimer's pathology. Family members can then learn their own options for predictive testing. Predictive testing is generally offered to adult relatives only when the familial variant is known.
At-risk adults need separate counseling before testing because a result affects care plans, work decisions, childbearing plans, and relationships. Children are not usually tested. Practical next steps include care planning, support services, safety planning, legal and financial planning, and discussion of research options. Ask the neurology team for a written care plan and information about research registries at the follow-up visit.
